|
Josh Bartoe, DVM, is currently Vice President of Ophthalmology Services and Attending Veterinarian at Northern Biomedical Research, headquartered in Norton Shores, Michigan. NBR is a contract research organization, based on the central western coast of Michigan, focused on targeted delivery expertise for CNS, ophthalmology, cardiology, and orthopedic indications. He is also the Director of Finance for Northern Biomolecular Services, also of Norton Shores. NBS is a contract research analytical laboratory focused on providing comprehensive, GLP-compliant qPCR-qRT-PCR assays to support development of gene, cell, and other biological therapeutics.
Dr. Bartoe is a Diplomate of the American College of Veterinary Ophthalmologists and started his career in academic medicine with Michigan State University College of Veterinary Medicine. During his 10 years with MSU, he also provided consulting ophthalmology services to MPI Research. He left MSU to become the Director of Ophthalmology Services at MPI in 2014. Following the Charles River acquisition of MPI, Dr. Bartoe was selected to lead the global CRL ocular center of excellence and was promoted to Senior Director of Ophthalmology Services for the Mattawan, Michigan, site. He has authored more than 30 peer-reviewed manuscripts focused primarily on the ocular gene therapy space, along with 6 textbook chapters. He is an active member of the Association for Research in Vision and Ophthalmology, American Society of Gene and Cell Therapy, Society of Toxicology, and the American College of Veterinary Ophthalmologists.